|
SUGT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.582600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.290960E-01 |
| Normal-vs-Stage2 |
2.706400E-01 |
| Normal-vs-Stage3 |
6.875600E-02 |
| Normal-vs-Stage4 |
8.344200E-01 |
| Stage1-vs-Stage2 |
7.017600E-01 |
| Stage1-vs-Stage3 |
3.200500E-04 |
| Stage1-vs-Stage4 |
2.930200E-01 |
| Stage2-vs-Stage3 |
3.467800E-02 |
| Stage2-vs-Stage4 |
3.597200E-01 |
| Stage3-vs-Stage4 |
7.305600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.256000E-01 |
| Normal-vs-AfricanAmerican |
7.905800E-01 |
| Normal-vs-Asian |
5.594800E-01 |
| Caucasian-vs-AfricanAmerican |
9.715600E-01 |
| Caucasian-vs-Asian |
5.839800E-01 |
| AfricanAmerican-vs-Asian |
5.899200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.392400E-01 |
| Normal-vs-Female |
2.717600E-01 |
| Male-vs-Female |
2.877600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.279400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.573000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.289200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.073000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.204200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.255600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.133600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.314400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.586600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.444200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.174100E-02 |
| Normal-vs-Grade 2 |
5.448200E-02 |
| Normal-vs-Grade 3 |
9.892200E-01 |
| Normal-vs-Grade 4 |
6.959700E-02 |
| Grade 1-vs-Grade 2 |
4.292400E-01 |
| Grade 1-vs-Grade 3 |
1.201220E-01 |
| Grade 1-vs-Grade 4 |
8.000600E-03 |
| Grade 2-vs-Grade 3 |
3.397600E-02 |
| Grade 2-vs-Grade 4 |
8.190000E-04 |
| Grade 3-vs-Grade 4 |
7.369600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.375300E-04 |
| Normal-vs-ccB subtype |
5.015700E-03 |
| ccA subtype-vs-ccB subtype |
4.00268707068108E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.625800E-01 |
| Normal-vs-N1 |
1.809580E-01 |
| N0-vs-N1 |
3.430000E-01 |
|
|
